167 related articles for article (PubMed ID: 2883873)
1. Effect of beta blockers on vascular resistance in systemic hypertension.
Man in 't Veld AJ
Am J Cardiol; 1987 May; 59(13):21F-25F. PubMed ID: 2883873
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension.
Man in 't Veld AJ; Schalekamp MA
Eur Heart J; 1983 Jul; 4 Suppl D():31-41. PubMed ID: 6137381
[TBL] [Abstract][Full Text] [Related]
3. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
Lund-Johansen P
Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of new beta-blockers with vasodilatory properties in essential hypertension.
Tsukiyama H; Otsuka K; Horii M
Drugs; 1988; 36 Suppl 6():48-54. PubMed ID: 2908304
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
Lund-Johansen P; Omvik P
Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
[TBL] [Abstract][Full Text] [Related]
7. The additional properties of beta adrenoceptor blocking drugs.
Prichard BN; Tomlinson B
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S1-15. PubMed ID: 2427833
[TBL] [Abstract][Full Text] [Related]
8. Beta blockers with intrinsic sympathomimetic activity.
White WB
Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
[TBL] [Abstract][Full Text] [Related]
9. Potential benefit of combination therapy with diuretics and beta blockers having intrinsic sympathomimetic activity.
Weinberger MH
Eur Heart J; 1990 Jun; 11(6):560-5. PubMed ID: 1972064
[TBL] [Abstract][Full Text] [Related]
10. Beta blockers in hypertension.
Thadani U
Am J Cardiol; 1983 Nov; 52(9):10D-15D. PubMed ID: 6139008
[TBL] [Abstract][Full Text] [Related]
11. Do beta-blockers really increase peripheral vascular resistance? Review of the literature and new observations under basal conditions.
Man in't Veld AJ; Van den Meiracker AH; Schalekamp MA
Am J Hypertens; 1988 Jan; 1(1):91-6. PubMed ID: 2897200
[TBL] [Abstract][Full Text] [Related]
12. The hemodynamic effects of adrenergic blocking agents.
Lund-Johansen P
Cleve Clin J Med; 1992; 59(2):193-200. PubMed ID: 1350235
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic and physiologic considerations of adrenoceptor blockade.
Frohlich ED; Dunn FG; Messerli FH
Am J Med; 1983 Oct; 75(4A):9-14. PubMed ID: 6139019
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of beta-receptor blockade during acute administration and chronic treatment.
Jensen HA
Acta Med Scand Suppl; 1982; 665():79-81. PubMed ID: 6130678
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of beta 1-selectivity and intrinsic sympathomimetic activity in a beta-adrenergic blocking drug.
Frishman WH
Am J Cardiol; 1987 May; 59(13):33F-37F. PubMed ID: 2883876
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
17. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients.
Eggertsen R; Andrén L; Sivertsson R; Hansson L
Eur J Clin Pharmacol; 1984; 27(1):19-22. PubMed ID: 6149128
[TBL] [Abstract][Full Text] [Related]
18. The effect of beta blockers on total peripheral resistance.
Man in 't Veld AJ; van den Meiracker A; Schalekamp MA
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S49-60. PubMed ID: 2427853
[TBL] [Abstract][Full Text] [Related]
19. Mode of action of beta-adrenergic blocking drugs in hypertension.
Prichard BN; Owens CW
Clin Physiol Biochem; 1990; 8 Suppl 2():1-10. PubMed ID: 1982756
[TBL] [Abstract][Full Text] [Related]
20. Around the beta-blockers, one more time.
Sproat TT; Lopez LM
DICP; 1991 Sep; 25(9):962-71. PubMed ID: 1683078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
